Alissa Wright

1.9k total citations
37 papers, 777 citations indexed

About

Alissa Wright is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, Alissa Wright has authored 37 papers receiving a total of 777 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 10 papers in Infectious Diseases and 9 papers in Surgery. Recurrent topics in Alissa Wright's work include Renal Transplantation Outcomes and Treatments (5 papers), Antifungal resistance and susceptibility (5 papers) and Pneumocystis jirovecii pneumonia detection and treatment (4 papers). Alissa Wright is often cited by papers focused on Renal Transplantation Outcomes and Treatments (5 papers), Antifungal resistance and susceptibility (5 papers) and Pneumocystis jirovecii pneumonia detection and treatment (4 papers). Alissa Wright collaborates with scholars based in Canada, United States and United Kingdom. Alissa Wright's co-authors include Jelena Ristic, Alan Kingstone, Theodore S. Steiner, Amee R. Manges, G J Gibson, J. A. Fishman, J J Gilmartin, Francisco A. Arabía, M. Rizwan Sohail and Randall C. Walker and has published in prestigious journals such as Clinical Infectious Diseases, Thorax and Vision Research.

In The Last Decade

Alissa Wright

36 papers receiving 752 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alissa Wright Canada 14 194 159 155 152 144 37 777
Evonne T Curran United Kingdom 14 56 0.3× 109 0.7× 260 1.7× 52 0.3× 200 1.4× 69 860
Roman Fleischhackl Austria 15 161 0.8× 338 2.1× 62 0.4× 72 0.5× 115 0.8× 35 784
Raymond C. Chan United States 17 191 1.0× 230 1.4× 32 0.2× 121 0.8× 90 0.6× 36 1.0k
Robert Straßl Austria 18 100 0.5× 470 3.0× 48 0.3× 50 0.3× 469 3.3× 92 1.6k
Charles A. Ellis United States 14 133 0.7× 224 1.4× 208 1.3× 21 0.1× 228 1.6× 50 955
Jon-Erik C Holty United States 18 174 0.9× 160 1.0× 182 1.2× 23 0.2× 138 1.0× 29 1.7k
Wai Ming Chan China 10 148 0.8× 359 2.3× 82 0.5× 37 0.2× 604 4.2× 29 1.2k
Johan Courjon France 13 129 0.7× 223 1.4× 180 1.2× 48 0.3× 187 1.3× 50 824
Yun Seong Kim South Korea 22 189 1.0× 277 1.7× 13 0.1× 260 1.7× 177 1.2× 126 1.5k
Karen Ka Yan Leung Canada 13 52 0.3× 129 0.8× 44 0.3× 20 0.1× 85 0.6× 88 740

Countries citing papers authored by Alissa Wright

Since Specialization
Citations

This map shows the geographic impact of Alissa Wright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alissa Wright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alissa Wright more than expected).

Fields of papers citing papers by Alissa Wright

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alissa Wright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alissa Wright. The network helps show where Alissa Wright may publish in the future.

Co-authorship network of co-authors of Alissa Wright

This figure shows the co-authorship network connecting the top 25 collaborators of Alissa Wright. A scholar is included among the top collaborators of Alissa Wright based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alissa Wright. Alissa Wright is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fitzpatrick, Tiffany, Juthaporn Cowan, Manish Sadarangani, et al.. (2025). Neurological adverse events following COVID-19 vaccination among Canadians referred to the special immunization clinic network. Vaccine. 59. 127254–127254. 1 indexed citations
2.
Lowe, Christopher F., et al.. (2023). Epidemiology of cytomegalovirus antiviral resistance testing for solid organ and bone marrow transplant patients from 2011 – 2019. Journal of Clinical Virology. 166. 105549–105549. 1 indexed citations
3.
Sharma, Atul, et al.. (2019). Valganciclovir prophylaxis delays onset of EBV viremia in high-risk pediatric solid organ transplant recipients. Pediatric Research. 87(5). 892–896. 4 indexed citations
4.
Levy, Robert D., John Yee, N. Partovi, et al.. (2018). Successful lung transplantation in an HIV seropositive patient with desquamative interstitial pneumonia: a case report. BMC Pulmonary Medicine. 18(1). 162–162. 9 indexed citations
5.
Camargo, Luís Fernando Aranha, Nassim Kamar, Eduardo Gotuzzo, & Alissa Wright. (2018). Schistosomiasis and Strongyloidiasis Recommendations for Solid-Organ Transplant Recipients and Donors. Transplantation. 102(2S). S27–S34. 19 indexed citations
6.
Wright, Alissa, et al.. (2017). An Exception to the Rule or a Rule for the Exception? The Potential of Using HIV-Positive Donors in Canada. Transplantation. 101(4). 671–674. 4 indexed citations
7.
Leung, Marianna, et al.. (2017). Clinical Pharmacokinetic Monitoring of Leflunomide in Renal Transplant Recipients with BK Virus Reactivation: A Review of the Literature. Clinical Pharmacokinetics. 56(9). 1015–1031. 8 indexed citations
8.
Gill, John S., Alissa Wright, Francis L. Delmonico, & Kenneth A. Newell. (2016). Towards Improving the Transfer of Care of Kidney Transplant Recipients. American Journal of Transplantation. 17(1). 54–59. 16 indexed citations
9.
Mah, Allison & Alissa Wright. (2016). Infectious Considerations in the Pre-Transplant Evaluation of Cirrhotic Patients Awaiting Orthotopic Liver Transplantation. Current Infectious Disease Reports. 18(2). 4–4. 8 indexed citations
10.
Stefanovic, Aleksandra, et al.. (2016). Positive blood cultures in a patient recovering from febrile neutropenia. JMM Case Reports. 3(3). e005038–e005038. 2 indexed citations
11.
Wright, Alissa, Jay A. Fishman, & Raymond T. Chung. (2014). Lamivudine Compared With Newer Antivirals for Prophylaxis of Hepatitis B Core Antibody Positive Livers: A Cost-Effectiveness Analysis. American Journal of Transplantation. 14(3). 629–634. 15 indexed citations
12.
Wright, Alissa & J. A. Fishman. (2014). Central Nervous System Syndromes in Solid Organ Transplant Recipients. Clinical Infectious Diseases. 59(7). 1001–1011. 35 indexed citations
13.
Kusne, Shimon, Talha Riaz, Randall C. Walker, et al.. (2013). Clinical Manifestations and Management of Left Ventricular Assist Device-Associated Infections. Clinical Infectious Diseases. 57(10). 1438–1448. 153 indexed citations
14.
Wright, Alissa, Sharon Unger, Brenda L. Coleman, Po-Po Lam, & Allison McGeer. (2012). Maternal Antibiotic Exposure and Risk of Antibiotic Resistance in Neonatal Early-onset Sepsis. The Pediatric Infectious Disease Journal. 31(11). 1206–1208. 12 indexed citations
15.
Wright, Alissa & Jason J.S. Barton. (2008). Viewpoint invariance in the discrimination of upright and inverted faces. Vision Research. 48(25). 2545–2554. 1 indexed citations
16.
Ristic, Jelena, Alissa Wright, & Alan Kingstone. (2007). Attentional control and reflexive orienting to gaze and arrow cues. Psychonomic Bulletin & Review. 14(5). 964–969. 93 indexed citations
17.
Ristic, Jelena, Alissa Wright, & Alan Kingstone. (2006). The number line effect reflects top-down control. Psychonomic Bulletin & Review. 13(5). 862–868. 99 indexed citations
18.
Adams, Philip C., G J Gibson, A R Morley, et al.. (1986). Amiodarone Pulmonary Toxicity: Clinical and Subclinical Features. QJM. 59(229). 449–71. 46 indexed citations
19.
Gilmartin, J J, Alissa Wright, & G J Gibson. (1985). Effects of pneumothorax or pleural effusion on pulmonary function.. Thorax. 40(1). 60–65. 38 indexed citations
20.
Wright, Alissa, et al.. (1982). Pulmonary infiltration and bone marrow depression complicating treatment with amiodarone.. BMJ. 284(6325). 1303–1303. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Evonne T Curran Breakdown of academic impact, for papers by Roman Fleischhackl Breakdown of academic impact, for papers by Raymond C. Chan Breakdown of academic impact, for papers by Robert Straßl Breakdown of academic impact, for papers by Charles A. Ellis Breakdown of academic impact, for papers by Jon-Erik C Holty Breakdown of academic impact, for papers by Wai Ming Chan Breakdown of academic impact, for papers by Johan Courjon Breakdown of academic impact, for papers by Yun Seong Kim Breakdown of academic impact, for papers by Karen Ka Yan Leung
Rankless by CCL
2026